Our immune systems weaken as we get older, making fewer cells that fight infection and help us recover from illness and injury. Scientists aren't completely sure why. They may have a better idea now, ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of ...

Variable feature selection was performed using the “vst” method to identify 2,000 highly variable ... where S and G2M scores were computed for each cell to determine its cell cycle state (Figures 3A, ...

Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like cells able to regenerate retinal tissue and support visual recovery.

The US Food and Drug Administration (FDA) approved the first CAR T-cell therapies in 2017 for diffuse large B-cell lymphoma and acute lymphoblastic leukemia in pediatric and young adult patients.

Quantification of Microsatellite Instability Testing and Detection of Lynch Syndrome: Step Forward in Improving Mismatch Repair Testing in Clinical Practice The introduction of T-cell–based ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases ...

Wojciech Jurczak, MD, PhD, discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase inhibitors and degraders. Wojciech Jurczak, MD, PhD, head of the department of ...